Literature DB >> 8162640

Stable pattern of stress coping in patients with rheumatoid arthritis.

V Günther1, E Mur, M Kurz, U Meise.   

Abstract

The stress coping mechanisms of patients with rheumatoid arthritis (74 women and 27 men) were compared to those of healthy controls (17 women and 16 men) using the Stress Coping Questionnaire of Janke et al. (1). Based on the duration of illness, male and female patients were divided into three groups, those with a duration of illness of less than 5 years, those with 5-15 years and a third group with 15 or more years of illness. From a comparison of these groups with healthy controls, the following conclusions can be drawn: (1) RA patients can be characterized by a coping pattern which is determined by significantly more cognitive mechanisms, e.g. trivialization, more attempts at controlling their reactions and less self-accusation. (2) The patient groups with different disease durations do not differ in their coping patterns. The stress coping behaviour of RA patients seems to be stable and does not appear to be influenced by the duration of illness.

Entities:  

Mesh:

Year:  1994        PMID: 8162640

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

1.  [Multidisciplinary treatment rheumatoid arthritis. Statistical and clinical change in pain experience].

Authors:  U Klages
Journal:  Schmerz       Date:  2005-02       Impact factor: 1.107

2.  The negative effect of decreasing the level of activity in coping with pain in rheumatoid arthritis: an increase in psychological distress and disease impact.

Authors:  W van Lankveld; G Näring; P van't Pad Bosch; L van de Putte
Journal:  J Behav Med       Date:  2000-08

3.  Withdrawal from labour force due to work disability in patients with ankylosing spondylitis.

Authors:  A Boonen; A Chorus; H Miedema; D van der Heijde; R Landewé; H Schouten; H van der Tempel; S van der Linden
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.